RPG Life Sciences Limited (RPGLIFE)

2,270.4

INR
-8.75(-0.38%)
As of December 13, 2024 9:59:00 AM

RPG Life Sciences Limited Share Price Information

24 hour Low and High

Low: 2270.4
High: 2270.4

All time High

2828.55

Price Change 1h

+₹-8.75 +-0.38%

Price Change 1d

+₹-8.75 +-0.38%

Price Change 1w

+₹112.75 +5.23%

RPG Life Sciences Limited Market Information

Exchange

NSE

Market Cap

₹4038.41 Cr

About RPG Life Sciences Limited Share

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmentics, anti-convulsant, and anti-spasmodic, etc. It also provides generics for immunosuppressant therapy; and finished dosage formulations for various therapies, which include nephrology, rheumatology, oncology, gastroenterology, cardiology, orthopedics, nutritional, diabetology, respiratory, neuropsychiatry, urology, vitamins and minerals, gastrointestinal, pain management, anti-diabetic, gynecology, cardiovascular, pediatrics, neurology, anti-dengue, and dermatology, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

1270

CEO

NA

Revenue (2023)

NA

NA

Country of Origin

India

Key Highlights

  • Are Robust Financials Driving The Recent Rally In RPG Life Sciences Limited's (NSE:RPGLIFE) Stock?
  • RPG Life Sciences Limited's (NSE:RPGLIFE) Shares Climb 26% But Its Business Is Yet to Catch Up
  • RPG Life Sciences standalone net profit declines 83.76% in the September 2024 quarter
  • Heidelberg Cement India, Coforge, and RPG Life Sciences clinch fresh 52-week high; here’s why
  • RPG Life Sciences' Stock Gains 7.17%, Receives 'Buy' Call from MarketsMOJO

FAQs

RPG Life Sciences Limited (RPGLIFE)

2,270.4

INR
-8.75(-0.38%)
As of December 13, 2024 9:59:00 AM

RPG Life Sciences Limited Share Price Information

24 hour Low and High

Low: 2270.4
High: 2270.4

All time High

2828.55

Price Change 1h

+₹-8.75 +-0.38%

Price Change 1d

+₹-8.75 +-0.38%

Price Change 1w

+₹112.75 +5.23%

RPG Life Sciences Limited Market Information

Exchange

NSE

Market Cap

₹4038.41 Cr

About RPG Life Sciences Limited Share

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmentics, anti-convulsant, and anti-spasmodic, etc. It also provides generics for immunosuppressant therapy; and finished dosage formulations for various therapies, which include nephrology, rheumatology, oncology, gastroenterology, cardiology, orthopedics, nutritional, diabetology, respiratory, neuropsychiatry, urology, vitamins and minerals, gastrointestinal, pain management, anti-diabetic, gynecology, cardiovascular, pediatrics, neurology, anti-dengue, and dermatology, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

1270

CEO

NA

Revenue (2023)

NA

NA

Country of Origin

India

Key Highlights

  • Are Robust Financials Driving The Recent Rally In RPG Life Sciences Limited's (NSE:RPGLIFE) Stock?
  • RPG Life Sciences Limited's (NSE:RPGLIFE) Shares Climb 26% But Its Business Is Yet to Catch Up
  • RPG Life Sciences standalone net profit declines 83.76% in the September 2024 quarter
  • Heidelberg Cement India, Coforge, and RPG Life Sciences clinch fresh 52-week high; here’s why
  • RPG Life Sciences' Stock Gains 7.17%, Receives 'Buy' Call from MarketsMOJO

FAQs